Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States

Gonadotropin-releasing hormone agonists (GnRHa's) are the standard treatment for children with central precocious puberty (CPP). We aim to present data on available GnRHa options with an easy-to-review table and discuss factors that influence treatment selection. Five GnRHa's are currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Popovic, Jadranka, Geffner, Mitchell E., Rogol, Alan D., Silverman, Lawrence A., Kaplowitz, Paul B., Mauras, Nelly, Zeitler, Philip, Eugster, Erica A., Klein, Karen O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577333/
https://www.ncbi.nlm.nih.gov/pubmed/36268040
http://dx.doi.org/10.3389/fped.2022.968485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577333/
https://www.ncbi.nlm.nih.gov/pubmed/36268040
http://dx.doi.org/10.3389/fped.2022.968485

Ejemplares similares